Ind-Swift Laboratories Limited

Nova Global bought 803,387 shares of Ind-Swift Laboratories for ₹11.09 Cr at ₹138.07 apiece in a bulk deal.

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

Nova Global Opportunities Fund PCC is a foreign portfolio investor that is an active anchor investor in Indian SME IPOs. It has backed offerings across sectors including electric equipment, power and energy, infrastructure, and logistics.